Compare ENTX & ACU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ENTX | ACU |
|---|---|---|
| Founded | 2010 | 1867 |
| Country | Israel | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Industrial Machinery/Components |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 142.0M | 145.9M |
| IPO Year | 2018 | N/A |
| Metric | ENTX | ACU |
|---|---|---|
| Price | $2.16 | $38.13 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $10.00 | N/A |
| AVG Volume (30 Days) | ★ 82.8K | 9.4K |
| Earning Date | 11-14-2025 | 10-21-2025 |
| Dividend Yield | N/A | ★ 1.73% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 2.45 |
| Revenue | $124,000.00 | ★ $194,960,991.00 |
| Revenue This Year | N/A | $3.05 |
| Revenue Next Year | N/A | $4.20 |
| P/E Ratio | ★ N/A | $15.13 |
| Revenue Growth | ★ 25.25 | 2.35 |
| 52 Week Low | $1.50 | $34.35 |
| 52 Week High | $3.22 | $45.25 |
| Indicator | ENTX | ACU |
|---|---|---|
| Relative Strength Index (RSI) | 36.71 | 47.72 |
| Support Level | $2.05 | $36.24 |
| Resistance Level | $2.53 | $38.16 |
| Average True Range (ATR) | 0.22 | 0.85 |
| MACD | -0.07 | 0.21 |
| Stochastic Oscillator | 13.42 | 59.02 |
Entera Bio Ltd is a clinical-stage biopharmaceutical company engaged in the development of orally delivered macromolecule therapeutics, including peptides and therapeutic proteins. The company focuses on underserved, chronic medical conditions where oral administration of a mini tablet peptide or peptide replacement therapy has the potential to significantly shift a treatment paradigm. Its product candidates are; EB613 for the treatment of osteoporosis and EB612 for the treatment of hypoparathyroidism are first-in-class mini tablet formulations of synthetic human PTH (1-34) (teriparatide), designed to have differing pharmacokinetic, or PK, profiles.
Acme United Corp is a supplier of first aid and medical products and cutting technology to the school, home, office, hardware, sporting goods, and industrial markets. Its principal products sold across all segments are first aid kits and medical products, scissors, shears, knives, rulers, pencil sharpeners, and sharpening tools. The Company sells its products to mass market and e-commerce retailers, industrial distributors, wholesale, contract, and retail stationery distributors, office supply superstores, sporting goods stores, and hardware chains. The Company's reportable business segments consist of the United States, Canada, and Europe, out of which the majority of the company's revenue is derived from the United States.